ClinicalTrials.gov
ClinicalTrials.gov Menu

This is an Early Study to Investigate the Effect of Gimatecan® in Adults With Malignant Glioma.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00032903
Recruitment Status : Completed
First Posted : April 8, 2002
Last Update Posted : June 3, 2009
Sponsor:
Collaborator:
Rhode Island Hospital
Information provided by:
Sigma-Tau Research, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Actual Study Completion Date : October 2005